RWI
CLDI icon

Red Wave Investments’s Calidi Biotherapeutics CLDI Stock Holding History

Red Wave Investments’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-421
Closed -$18.6K – 109
2025
Q2 		$18.6K Hold
421
– – 0.01% 109
2025
Q1 		$45.8K Hold
421
– – 0.02% 97
2024
Q4 		$93K Buy
421
+179
+74% +$53.7K 0.03% 105
2024
Q3 		$53K Sell
242
-83
-26% -$23.1K 0.02% 109
2024
Q2 		$125K Sell
325
-11
-3% -$5.62K 0.05% 102
2024
Q1 		$364K Buy
336
+307
+1,059% +$502K 0.14% 69
2023
Q4 		$85.4K Hold
29
– – 0.03% 99
2023
Q3 		$188K Buy
+29
New +$470K 0.08% 91

Other funds holding CLDI

HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

Red Wave Investments's CLDI Position: Q3 2025 in Review

Red Wave Investments sold out of Calidi Biotherapeutics (CLDI) in Q3 2025, closing a stake of 421 shares — an estimated $18.6K sold.

Red Wave Investments first reported a position in CLDI in Q3 2023 and held it in 8 quarters. The position peaked at $364K in Q1 2024. 21 funds tracked by Wall St. Rank hold CLDI as of Q3 2025.

  • Red Wave Investments reported no remaining Calidi Biotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Red Wave Investments sold 421 Calidi Biotherapeutics shares in Q3 2025, an estimated $18.6K.
  • Red Wave Investments first reported a position in Calidi Biotherapeutics in Q3 2023 and held it in 8 quarters.
  • Red Wave Investments's Calidi Biotherapeutics position peaked at $364K in Q1 2024.
  • 21 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q3 2025.

Based on Red Wave Investments's 13F filing for Q3 2025, filed 28 Oct 2025.